Predictors of Chronic Obstructive Pulmonary Disease Exacerbation Reduction in Response to Daily Azithromycin Therapy

Rationale: Daily azithromycin decreases acute exacerbations of chronic obstructive pulmonary disease (AECOPD), but long-term side effects are unknown. Objectives: To identify the types of exacerbations most likely to be reduced and clinical subgroups most likely to benefit from azithromycin, 250 mg...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Respir Crit Care Med
Main Authors: Han, MeiLan K., Tayob, Nabihah, Murray, Susan, Dransfield, Mark T., Washko, George, Scanlon, Paul D., Criner, Gerard J., Casaburi, Richard, Connett, John, Lazarus, Stephen C., Albert, Richard, Woodruff, Prescott, Martinez, Fernando J.
Formato: Artigo
Idioma:Inglês
Publicado em: American Thoracic Society 2014
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4226018/
https://ncbi.nlm.nih.gov/pubmed/24779680
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201402-0207OC
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados